Agnete Fredriksen | President And Chief Scientific Officer
Vaccibody AS | Norway

Agnete Fredriksen, President And Chief Scientific Officer, Vaccibody AS

Agnete B. Fredriksen is Co-Founder, President and Chief Scientific Officer of Vaccibody AS. She holds a M.Sc., Ph.D from Institute of Immunology, University of Oslo, Rikshospitalet in Norway where she designed and developed the first Vaccibody vaccines. Agnete is one of the inventors of the Vaccibody technology and received the King’s Gold Medal for her PhD thesis on Vaccibodies. Her focus is on bringing innovative cancer vaccines from idea to clinical development. Previous employment includes Affitech AS and Medinnova AS. Agnete is author on numerous scientific papers in the field of immunology, immunotherapy and vaccines. Inventor on several patents in the field of immunotherapy. She is board member for the BIA programme of NRC stimulating innovation in the Norwegian industry.


Oct 29th Day 1 @ 17:15

Developing personalized neoantigen cancer vaccines to target solid tumors

- Inducing a unique CD8-dominated T cell response- Clinical updates on phase I/IIa VB10.NEO vaccine trial
last published: 16/Sep/19 14:05 GMT

back to speakers

Sign Up for Event Updates